• Safi Bello

Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production

Sanofi press release ---- Sanofi and Lonza announced today that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The strategic partnership in the form of a joint venture combines the strong biologics development pipeline of Sanofi with the expertise of Lonza to design, construct, start-up and operate a state-of-the-art large-scale mammalian cell culture facility. The initial investment will be around CHF 290 million (€ 270 million), to be split equally between each company. The initial phase of the facility will commence construction in 2017, pending necessary regulatory approvals, and is expected to be fully operational by 2020. Lonza has previously built and licensed three similar facilities in the U.S. and Singapore. To get more in depth information on Sanofi and Lonza entering into a strategic partnership to establish a large scale biologics production facility click on the picture below to read the release.

1 view0 comments

© 2020 Safi Bello A Girls How To Guide